rAAV1-CB-hAAT

· Beacon Therapeutics

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for rAAV1-CB-hAAT, covering 2012-09-14 to 2012-09-14. Get the full timeline:

Most recent: Clinical Trial Update: Safety & Efficacy Study of rAAV1-CB-hAAT for Alpha-1 Antitrypsin Deficiency [Phase 2]